正在加载公司
Just reported
Q3 2026 results
From Stryker's results release of 2026年10月29日; its quarterly report has since been filed.
Revenue
Actual
US$6.52B
+7.6% y/y
-1.0% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$1.96
-12% y/y
-41% q/qGuided
—
No guide given
Operating income, GAAP
Actual
US$1.03B
-8.9% y/y
-38% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Stryker is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plcUS$131.6BA+
EWEdwards Lifesciences CorporationUS$61.6BA+
GEHCGE Healthcare Technologies Inc.US$37.5BA
GKOSGlaukos CorpUS$14.5BA
PENPenumbra, IncUS$12.7BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A- EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
- GEHCGE Healthcare Technologies Inc.2026年10月28日CAGraded C, now A
怎么赚钱
- MedSurg and Neurotechnology products55%
- Orthopaedics products45%
各项收入占比是对nine months ended 2026-09-30的估算，并非来自已提交报告的数字。
竞争对手
卖什么6
Surgical instruments and navigation systems
Powered surgical tools and navigation equipment that help surgeons carry out procedures.
Endoscopy and communications equipment
Cameras and related equipment that let clinicians view inside the body, alongside systems that connect operating-room equipment.
Patient and emergency-care equipment
Hospital beds, patient-handling equipment, emergency monitors and defibrillators, intensive-care disposables, and clinician communication systems.
再显示 3 项
Minimally invasive vascular devices
Catheters and other devices used in minimally invasive treatment of stroke and venous blood clots.
Brain and cranial surgery products
Products for brain and open-skull surgery, including synthetic bone grafts and products used to treat spinal bone conditions.
Joint and trauma implants and robotic surgery systems
Hip, knee, shoulder, ankle and trauma implants, plus robotic systems and surgical tools used in these operations.
谁在买4
- Hospitals and health systems buy operating-room, patient-care, emergency and communication equipment, often directly from Stryker.
- Surgeons and other physicians select implants, instruments and procedural devices for operations; hospitals or other healthcare facilities are often the paying buyers.
- Emergency medical services providers and other healthcare facilities buy emergency-care equipment.
- Third-party dealers and distributors buy or resell products to healthcare providers.
靠什么支撑，什么会击垮它
业务依赖什么
- 1Some raw materials are sourced from single suppliers, so supply interruptions could affect manufacturing.
- 2The business depends on medical-device approvals, clinical testing and ongoing compliance with United States and foreign regulations.
- 3Sales depend on hospitals' and healthcare providers' ability and willingness to buy equipment, and on procedure volumes, pricing and reimbursement.
可能出什么问题
- 1A cybersecurity incident in the first quarter of 2026 disrupted operations and production; system recovery, security work and related costs remain exposures.
- 2Supply constraints at a plant serving the Peripheral Vascular business caused backorders and lost sales; the business's operating outlook has also been affected by supply and market conditions.
- 3Medical-device approval and quality rules can delay products or require costly changes, while product recalls, liability claims and healthcare cost controls can affect sales and costs.
关于Stryker Corp.
Stryker makes equipment used during operations and in hospital wards, including cameras, surgical instruments, beds, emergency devices and systems that help hospital staff communicate. It also makes minimally invasive devices to treat strokes and blood clots, plus implants and robotic systems used in joint replacement and trauma surgery. It sells mainly to doctors, hospitals and other healthcare facilities, both directly and through distributors.
- 总部
- Kalamazoo, Michigan, United States
- 成立于
- 1941
- 员工人数
- approximately 56,000 (2025-12-31, high)
- 上市于
- NYSE
- 财年结束
- December 31
基于 Stryker Corp. 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。